Adma Biologics Inc. (ADMA)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts
In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.
ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform
ADMA's growth remains centered on Asceniv, Bivigam, and NABI-HB. These are its main value drivers today. ADMA Biologics' recent Q2 report showed that the company is working on enhancing its plasma yields by over 20% in IG output. This should help them with margin expansion beginning in 2026. ADMA also reaffirmed its guidance for over $500 million in 2025 revenues and over $625 million by 2026. Its long-term goal remains at over $1.1 billion in sales pre-2030.
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
ADMA Biologics' Q2 earnings and revenue beat can be attributed to Asceniv growth. However, shares fall 7.4% in after-hours trading.
ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Adam S. Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer Skyler Bloom - Senior Director of Business Development & Corporate Strategy Conference Call Participants Anthony Charles Petrone - Mizuho Securities USA LLC, Research Division Gary Jay Nachman - Raymond James & Associates, Inc., Research Division Richard V.
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates
Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.13 per share a year ago.
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Adma Biologics (ADMA) closed at $18.59, marking a +1.81% move from the previous day.
Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts
The latest trading day saw Adma Biologics (ADMA) settling at $18.26, representing a +1.44% change from its previous close.
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
Adma Biologics (ADMA) concluded the recent trading session at $17.13, signifying a +2.39% move from its prior day's close.
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors
In the most recent trading session, Adma Biologics (ADMA) closed at $17.98, indicating a -3.75% shift from the previous trading day.
Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know
Adma Biologics (ADMA) concluded the recent trading session at $18.34, signifying a +2.98% move from its prior day's close.
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
